target audience: TECH BUYER Publication date: Jun 2023 - Document type: IDC Perspective - Doc Document number: # US49196923
IDC Perspective: Why Is 5G High on Pharma's Radar?
Content
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.
Related Links
Abstract
This IDC Perspective examines why the adoption of 5G is growing so rapidly, which are the key use cases for the life science industry, and where the roadblocks lie and provides guidance to technology buyers.
"As 5G technology becomes increasingly pervasive, as patients go remote, and as the adoption of decentralized clinical trials continues to grow, the life science industry will increasingly invest in this technology, not only to deepen patient engagement and retention but also to explore newer terrain, such as telepathology, smart factories, intelligent supply chain, and digital twins. The promise of widely available high-bandwidth, high-reliability edge computing and expansive network capability that 5G has to offer is a game changer for pharma, biotechs, and medical device companies," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.